Search Results - "Astone, Janetta M."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Medical Examinations at Entry to Treatment for Drug Abuse as an Opportunity to Initiate Care for Hepatitis C Virus Infection by Hagan, Holly, Strauss, Shiela M., Astone, Janetta M., Des Jarlais, Don C.

    Published in Clinical infectious diseases (15-04-2005)
    “…Over the course of addiction, a substantial proportion of drug users enter drug abuse treatment programs. Data from a cross-sectional survey of drug abuse…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States by Strauss, Shiela M, Astone, Janetta M, Jarlais, Don Des, Hagan, Holly

    Published in Drug and alcohol dependence (08-03-2004)
    “…Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic…”
    Get full text
    Journal Article
  3. 3

    The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units by Strauss, Shiela M, Astone, Janetta M, Hagan, Holly, Des Jarlais, Don C

    Published in Journal of urban health (01-03-2004)
    “…Although drug users are at elevated risk for hepatitis C virus (HCV) infection, many are uniformed or misinformed about the virus. Drug treatment programs are…”
    Get full text
    Journal Article
  4. 4

    Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units by Strauss, Shiela M, Astone, Janetta M, Des Jarlais, Don C, Hagan, Holly

    Published in AIDS patient care and STDs (01-02-2005)
    “…Hepatitis C virus (HCV) is the most prevalent blood-borne infectious disease in the United States, especially among drug users, and coinfection with HIV is…”
    Get more information
    Journal Article
  5. 5

    Outpatient Drug Treatment Program Directors' Hepatitis C-Related Beliefs and Their Relationship to the Provision of HCV Services by Astone, Janetta M., Strauss, Shiela M., Hagan, Holly, Des Jarlais, Don C.

    “…The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug-abusing population. Therefore, drug users…”
    Get full text
    Journal Article
  6. 6

    Provision of on-site medical care to patients with hepatitis C in drug treatment units by Vassilev, Zdravko P, Strauss, Shiela M, Astone, Janetta M, Friedmann, Peter D, Des Jarlais, Don C

    “…Substance abusers are at high risk for hepatitis C (HCV) infection and also constitute a group that is medically underserved and hard to reach. We conducted a…”
    Get more information
    Journal Article
  7. 7

    Residential Substance User Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives by Strauss, Shiela M., Astone, Janetta M., Munoz-Plaza, Corrine, Hagan, Holly, Jarlais, Don Des

    Published in Substance use & misuse (2005)
    “…Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication…”
    Get full text
    Journal Article
  8. 8

    Drug Treatment Programs as Sites of Opportunity for the Delivery of Hepatitis C Prevention Education: Client and Staff Perspectives by Munoz-Plaza, Corrine E., Strauss, Shiela M., Astone, Janetta M., Des Jarlais, Don C., Hagan, Holly

    Published in Journal of drug issues (01-10-2004)
    “…This paper uses qualitative methods to examine both staff and clients' perceptions about the delivery of hepatitis C prevention education services at their…”
    Get full text
    Journal Article
  9. 9

    Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S by Strauss, Shiela M., Rindskopf, David M., Astone-Twerell, Janetta M., Des Jarlais, Don C., Hagan, Holly

    Published in Drug and alcohol dependence (09-06-2006)
    “…Hepatitis C virus (HCV) infection is a global health problem, and in many countries (including the U.S.), illicit drug users constitute the group at greatest…”
    Get full text
    Journal Article
  10. 10

    Research Note: Perspectives on the Hierarchy of HIV and Hepatitis C Disease: Consequences for Drug Treatment Program Patients by Munoz-Plaza, Corrine, Strauss, Shiela M., Tiburcio, Nelson, Astone-Twerell, Janetta M., Des Jarlais, Don C., Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew

    Published in Journal of drug issues (01-04-2010)
    “…Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the…”
    Get full text
    Journal Article
  11. 11

    HCV (Hepatitis C Virus) Pre-Test and Post-Test Counseling Services at Drug Treatment Programs: Missed Opportunities for Primary Prevention by Munoz-Plaza, Corrine E, Strauss, Shiela M, Astone, Janetta M, Des Jarlais, Don C, Hagan, Holly

    Published in Contemporary drug problems (22-12-2005)
    “…Although drug users are at risk for hepatitis C virus (HCV) infection, many clients in drug treatment programs remain uninformed about their HCV serostatus…”
    Get full text
    Journal Article
  12. 12

    Staff Perspectives on Facilitating the Implementation of Hepatitis C Services at Drug Treatment Programs by Munoz-Plaza, Corrine E., Strauss, Shiela M., Astone-Twerwll, Janetta M., Des Jarlais, Don C., Hagan, Holly

    Published in Journal of psychoactive drugs (01-09-2006)
    “…Drug users are at risk of acquiring the hepatitis C virus (HCV). Although ancillary services available to clients at drug treatment programs are often limited,…”
    Get full text
    Journal Article
  13. 13

    Hepatitis C Knowledge among Staff in U.S. Drug Treatment Programs by Strauss, Shiela M, Astone-Twerell, Janetta M, Munoz-Plaza, Corrine, Des Jarlais, Don C, Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew

    Published in Journal of drug education (01-01-2006)
    “…Staff in drug treatment programs are in an optimal position to support the hepatitis C related needs of their patients. To do so effectively, however, staff…”
    Get more information
    Journal Article
  14. 14

    Correlates of Drug Treatment Program Staff's Self Efficacy to Support Their Clients' Hepatitis C Virus (HCV) Related Needs by Strauss, Shiela M., Astone-Twerell, Janetta M., Munoz-Plaza, Corrine, Des Jarlais, Don C., Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew

    “…Drug treatment staff are uniquely situated to support their clients' HCV related needs, and those with greater self efficacy to do so are more likely to…”
    Get full text
    Journal Article
  15. 15

    Drug treatment programs' HCV service delivery to their HCV positive clients by Astone-Twerell, Janetta M., Strauss, Shiela M., Hagan, Holly, Des Jarlais, Don C.

    Published in Addiction research & theory (01-01-2006)
    “…Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to…”
    Get full text
    Journal Article
  16. 16

    Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs by Vassilev, Zdravko P, Strauss, Shiela M, Astone, Janetta, Des Jarlais, Don C

    “…Drug treatment facilities are important sites for providing targeted prevention and health services to injection drug users (IDUs) who are infected with the…”
    Get full text
    Journal Article
  17. 17

    Perspectives On The Hierarchy Of HIV And Hepatitis C Disease: Consequences For Drug Treatment Program Patients by Munoz-Plaza, Corrine, Strauss, Shiela M, Tiburcio, Nelson, Astone-Twerell, Janetta M, Des Jarlais, Don C, Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew

    Published in Journal of drug issues (01-04-2010)
    “…Injection drug users (IDUs) face an increased risk of acquiring blood borne viral infections, including HIV and the hepatitis C virus (HCV). However, the…”
    Get full text
    Journal Article